Network News
Today, we announced that our company won two awards from the annual CDMO Leadership Awards, sponsored by Outsourced Pharma and Life Science Connect. AGC Biologics was named a winner in both the “Biologics – Global” and “Cell & Gene – Global” categories and is one of the few in the industry that scored high enough […]
read more
Celonic Group Leverages Merck’s Breez™ Micro-Bioreactor Platform, Enabling Next-Generation Perfusion-Based Bioprocessing.
Basel, Switzerland, 12 March 2025 – Celonic Group, a Swiss-Based Quality contract development and manufacturing organization (CDMO), has announced that it is integrating Merck’s Breez™ micro-bioreactor platform into its process development. This addition will further enhance Celonic’s capabilities in monoclonal antibody (mAb) development and manufacturing by enabling highly efficient, scalable perfusion-based bioprocessing from early-stage development to […]
read more
Hepatic stellate cells control liver function and regeneration
Until now, doctors knew hepatic stellate cells mainly as drivers of liver fibrosis. The actual functions of this cell type have hardly been studied to date. Researchers from the German Cancer Research Center (DKFZ), the Mannheim Medical Faculty and Columbia University in New York have now published in the journal Nature that hepatic stellate cells […]
read more
Dieter Schwarz Foundation provides long-term funding for application-oriented basic research and innovative talent pool
Together with the Max Planck Society, the foundation promotes pioneering research and talent in Heilbronn The Max Planck Society and the Dieter Schwarz Foundation (DSS) have embarked on a groundbreaking initiative. On March 13, 2025, they signed an agreement through which the foundation will support an innovative approach by the Max Planck Institute for Medical […]
read more
Scientists discover the function of a mysterious HIV component
A research team including scientists from Heidelberg University Hospital has gained new insights into HIV-1. Researchers from Martinsried, Heidelberg und Yale have discovered the mechanism behind an important step in the life cycle of HIV. Working together with teams at Heidelberg and Yale Universities, they found that the enigmatic “spacer peptide 2”, one of the […]
read more
Early Excellence in Science Award for Ivana Winkler
The Bayer Foundation’s Early Excellence in Science Award 2024 in the category of Data Science goes to Ivana Winkler of the German Cancer Research Center (DKFZ). Winkler’s work uncovered the unexpected effect of female reproductive capacity: the constantly recurring remodeling of the organs of the female reproductive tract during the sexual cycle leads to fibrosis […]
read more
Recognise developmental disorders early with AI: Automatically classifying movement patterns in babies
Using a new combination of three sensors and artificial intelligence, researchers at Heidelberg Medical Faculty of Heidelberg University and Heidelberg University Hospital are recognising patterns in babies’ movements that show whether their nervous system is developing healthily. The way an infant moves spontaneously in the first few months of life can indicate whether its nervous system […]
read more
Frank Winkler receives the Brain Prize 2025
This year, the most highly endowed award in the neurosciences and neuromedical research honors pioneering work on the interactions between the nervous system and brain tumors: Neurologist Frank Winkler, who conducts research at the University of Heidelberg and at the German Cancer Research Center (DKFZ) and treats patients with brain tumors at Heidelberg University Hospital, […]
read more
Understanding rare diseases with digital twins
New EMBL-EBI project explores the use of a concept developed in aerospace engineering to support rare disease research, diagnosis, and treatment Rare diseases are individually uncommon, but together they affect over 300 million people worldwide. There are more than 7,000 conditions that are classed as rare diseases, and many of them don’t have approved treatments. […]
read more
